LD Arnold… - Archives of internal medicine, 2011 - Am Med Assoc The benefit of BSO is well established for those with a known genetic risk for ovarian and breast cancer (eg, BRCA1 [GenBank U14680] and BRCA2 [GenBank U43746] carriers). 3-4 However, there is a lack of consistent scientific evidence in support of (or against) ... Cited by 1 - Related articles - All 3 versions
[PDF] from foroaps.orgAZ LaCroix, RT Chlebowski… - JAMA: The Journal of …, 2011 - Am Med Assoc Author Affiliations: Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington (Dr LaCroix and Mr Aragaki); Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California (Dr Chlebowski); Division of ... Cited by 21 - Related articles - All 6 versions
B Rosner… - Annals of epidemiology, 2011 - Elsevier We followed 38,948 premenopausal women in 1980 and identified 2,586 who reported hysterectomy without bilateral oophorectomy and 31,626 who reported natural menopause during 22 years of follow-up. We evaluated risk factors for natural menopause, imputed age at natural ... Cited by 2 - Related articles - All 5 versions
VL Jacoby, D Grady, J Wactawski-Wende… - Archives of internal …, 2011 - Am Med Assoc Methods This is a prospective cohort of 25 448 postmenopausal women aged 50 to 79 years enrolled in the Women's Health Initiative Observational Study who had a history of hysterectomy and BSO (n = 14 254 [56.0%]) or hysterectomy with ovarian conservation (n = 11 194 ... Cited by 3 - Related articles - All 3 versions
[CITATION] … . Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
